These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2877109)

  • 1. Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent, and the corresponding desoxy derivative (YM-11133) in rats.
    Honda K; Nakagawa C; Inagaki O; Shibasaki M; Takenaka T; Takeda M
    Jpn J Pharmacol; 1986 Aug; 41(4):459-66. PubMed ID: 2877109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
    Honda K; Takenaka T; Miyata-Osawa A; Terai M
    J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
    Uchida W; Shibasaki K; Asano M; Takenaka T
    Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New sulfamoylphenethylamines, potent alpha 1-adrenoceptor antagonists.
    Takenaka T; Honda K; Fujikura T; Niigata K; Tachikawa S; Inukai N
    J Pharm Pharmacol; 1984 Aug; 36(8):539-42. PubMed ID: 6148398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs.
    Takenaka T; Asano M; Berdeaux A; Giudicelli JF
    Eur J Pharmacol; 1982 Nov; 85(1):35-50. PubMed ID: 6129981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent.
    Asano M; Uchida W; Shibasaki K; Terai M; Inagaki O; Takenaka T; Matsumoto Y; Fujikura T
    J Pharmacol Exp Ther; 1990 Jul; 254(1):204-11. PubMed ID: 1973196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity and specificity for alpha 1-adrenoceptor blocking activity of R(-)- and S(+)-YM-12617 orally administered to pithed, spontaneously hypertensive rats.
    Honda K; Momose N; Nakagawa C
    J Pharm Pharmacol; 1987 Apr; 39(4):316-8. PubMed ID: 2884301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium entry blocking, beta 1-adrenoceptor blocking and hypotensive effects of YM-16151-4.
    Shibasaki K; Uchida W; Matsuda Y; Asano M
    Arch Int Pharmacodyn Ther; 1991; 313():140-50. PubMed ID: 1687772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on (+/-)-YM-12617, a potent and selective alpha 1-adrenoceptor antagonist and its individual optical enantiomers.
    Honda K; Nakagawa C; Terai M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):295-302. PubMed ID: 2891044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs.
    Shibasaki M; Sudoh K; Inagaki O; Uchida W; Honda K
    J Auton Pharmacol; 1992 Aug; 12(4):263-8. PubMed ID: 1355094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
    Uchida W; Shibasaki K; Matsuda Y; Asano M; Takenaka T
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):247-52. PubMed ID: 7692165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W; Shibasaki K; Asano M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein.
    Doggrell SA
    Chirality; 1993; 5(1):8-14. PubMed ID: 8095397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the enantiomers of 3-0-methyldobutamine, a metabolite of dobutamine, with alpha- and beta-adrenoreceptors in the cardiovascular system of the pithed rat.
    Ruffolo R; Morgan EL
    J Auton Pharmacol; 1984 Dec; 4(4):295-302. PubMed ID: 6099363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac effects of YM-09538, a new alpha- and beta-adrenoceptor blocking agent, on SA nodal pacemaker activity and contractility in isolated atria and intact dogs.
    Chiba S; Watanabe H; Furukawa Y; Iwatsuki K
    Jpn Heart J; 1982 Jul; 23(4):631-6. PubMed ID: 6127420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.